1991-1997 – Marmara Üniversitesi Tıp Fakültesi – Hematoloji Üst İhtisası
1985-1991 – 19 Mayıs Üniversitesi– İç Hastalıkları Uzmanlık Eğitimi
1979-1985 – Hacettepe Üniversitesi, 19 Mayıs Üniversitesi – Tıp Fakültesi
Çalıştığı Kurumlar
2010- Halen – Acıbadem LabCell– Kök Hücre Laboratuvarı ve Kordon Kanı Bankası Mesul Müdürü
1998 – 2007 – Sağlık Bakanlığı Kordon Kanı Bankaları Koordinasyon Kurulu Başkanı
1998 – 2007 – Karadeniz Teknik Üniversitesi Kemik İliği Merkezi Sorumlusu
1992 – 2010 – Karadeniz Teknik Üniversitesi Hematoloji Bilim Dalı Öğretim Üyeliği
Bilimsel Yayınlar
Tastan C, Yurtsever B, Sir G, Dilek Kancagi D, Demir S, Abanuz S, Seyis U, Yildirim M, Kuzay R, Elibol O, Arbak S, Acikel Elmas M, Birdogan S, Sahin E, Ozcan O, Sezerman U, Ovali E. SARS-CoV-2 Isolation and Propagation from Turkish COVID-19 patients. BioRxiv April 2020. doi:https://doi.org/10.1101/2020.04.23.056309.
Yalcin K., Ovali E., Ozdamarlar U., Celen S., Karasu G., Yesilipek A. & Hazar V. NK-92 cellular therapy for pediatric relapsed/refractory Ewing sarcoma.International Cancer Conference Journal (2020).
Celilova S, Toret E, Adaklı Aksoy B, Ovalı E, Bozkurt C. CMV Specific T Cells for Treatment of CMV Infection After Hematopoietic Stem Cell Transplantation in a Pediatric Case: First Application in Turkey. 2020 Feb 20;37(1):65-67.
Batioglu-Karaaltin A, Ovali E, Karaaltin MV, Yener M, Yılmaz M, Eyüpoğlu F, Yılmaz YZ, Bozkurt ER, Demir N, Konuk E, Bozdağ ES, Yiğit Ö, Cansiz H. Decellularization of Trachea With Combined Techniques for Tissue-Engineered Trachea Transplantation. Clin Exp Otorhinolaryngol. 2019 Feb;12(1):86-94.
Erbey F, Akçay A, Atay D, Ovalı E, Öztürk G. Comparison of outcomes after HLA-matched unrelated and αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation for children with high-risk acute leukemia. Pediatr Transplant. 2018 Jun;22(4):e13192.
Batioglu-Karaaltin A, Karaaltin MV, Oztel ON, Ovali E, Sener BM, Adatepe T, Yigit O, Bozkurt E, Baydar SY, Bagirova M, Uzun N, Allahverdiyev A. Human olfactory stem cells for injured facial nerve reconstruction in a rat model. Head Neck. 2016 Apr;38 Suppl 1:E2011- 20.
Erbey F, Atay D, Akcay A, Ovali E, Ozturk G. Mesenchymal Stem Cell Treatment for Steroid Refractory Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey. Stem Cells Int. 2016;2016:1641402. doi: 10.1155/2016/1641402.
Canter HI, Karaaltin MV, Ovali E, Yogun FN, Baygol EG, Kaplan S. Generation of Skin Tissue Using Adipose Tissue-Derived Stem Cells. Ozpur MA, Guneren E, Plast Reconstr Surg. 2016 Jan;137(1):134-43.
Akgun I, Unlu MC, Erdal OA, Ogut T, Erturk M, Ovali E, Kantarci F, Caliskan G, Akgun Y. Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2- year randomized study. Arch Orthop Trauma Surg. 2015 Feb;135(2):251-263.
Batioglu-Karaaltin A, Karaaltin MV, Ovali E, Yigit O, Kongur M, Inan O, Bozkurt E, Cansiz H. In vivo tissue-engineered allogenic trachea transplantation in rabbits: a preliminary report. Stem Cell Rev Rep. 2015 Apr;11(2):347-56.
Cakmak O, Babakurban ST, Akkuzu HG, Bilgi S, Ovalı E, Kongur M, Altintas H, Yilmaz B, Bilezikçi B, Celik ZY, Yakicier MC, Sahin FI. Injectable tissue-engineered cartilage using commercially available fibrin glue. Laryngoscope. 2013 Dec;123(12):2986-92..
Uçar F, Sönmez M, Erkut N, Balcı M, Yücel B, Yılmaz M, Erduran E, Ovalı E. Relation of HLA-A, -B, -DRB1 alleles and haplotypes in patients with acute leukemia: a case control study. Arch Med Res. 2011 May;42(4):305-10.
Sonmez M, Saglam F, Karahan SC, Erkut N, Mentese A, Sonmez B, Ucar F, Topbas M, Ovali E. Treatment related changes in antifibrinolytic activity in patients with polycythemia vera. Hematology. 2010 Dec;15(6):391-6.
Atasoy A, Sevim Y, Kaya I, Yilmaz M, Durmus A, Sonmez M, Omay SB, Ozdemir F, Ovali E. The effects of electromagnetic fields on peripheral blood mononuclear cells in vitro. Bratisl Lek Listy. 2009;110(9):526-9.
Sayitoglu M, Haznedaroğlu IC, Hatirnaz O, Erbilgin Y, Aksu S, Koca E, Adiguzel C, Bayik M, Akalin I, Gülbas Z, Akay M, Unal A, Kaynar L, Ovali E, Yilmaz M, Yenerel M, Dagdas S, Ozet G, Ar C, Aydin Y, Soysal T, Durgun B, Ozcebe O, Tukun A, Ilhan O, Ozbek U. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia. J Int Med Res. 2009 Jul-Aug;37(4):1018-28.
Sonmez M, Akagun T, Cobanoglu U, Topbas M, Erkut N, Yilmaz M, Ovali E, Omay SB. Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate. Hematology. 2009 Aug;14(4):220-3.
Sonmez M, Arslan M, Cobanoglu U, Kavgaci H, Ozbas HM, Aydin F, Ovali E, Omay SB. Association of gastrointestinal stromal tumor and acute myeloid leukemia preceded by myelodysplastic syndrome with refractory anemia. Tumori. 2009 Mar-Apr;95(2):240-2. Uzun Y, Akdogan E, Ozdemir F, Ovali E. The effects of heparin on DLD-1 colon cancer cell line. Bratisl Lek Listy. 2009;110(1):3-6.
Kozanoglu I, Boga C, Ozdogu H, Maytalman E, Ovali E, Sozer O. A detachment technique based on the thermophysiologic responses of cultured mesenchymal cells exposed to cold. Cytotherapy. 2008;10(7):686-9. doi: 10.1080/14653240802419294.
Effect of pathologic fractures on survival in multiple myeloma patients: a case control study. Sonmez M, Akagun T, Topbas M, Cobanoglu U, Sonmez B, Yilmaz M, Ovali E, Omay SB. J Exp Clin Cancer Res. 2008 Jun 10;27:11.
Sonmez M, Cobanoglu U, Ovali E, Omay SB. Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure. J Clin Pharm Ther. 2008 Jun;33(3):329-30.
Sonmez M, Bektas O, Yilmaz M, Durmus A, Akdogan E, Topbas M, Erturk M, Ovali E, Omay SB. The relation of lymphoma and hepatitis B virus/hepatitis C virus infections in the region of East Black Sea, Turkey. Tumori. 2007 Nov-Dec;93(6):536-9.
Yilmaz M, Ovali E, Akdogan E, Durmus A, Sonmez M, Dikmen T, Omay SB. Autologous serum is more effective than fetal bovine serum on proliferation of bone marrow derived human mesenchymal stem cells. Saudi Med J. 2008 Feb;29(2):306-9.
Sonmez M, Ovali E, Omay SB. Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase. J Clin Pharm Ther. 2008 Feb;33(1):91-2.
Yilmaz M, Dikmen T, Sonmez M, Akdogan E, Durmus A, Omay SB, Ovali E. Change of coagulation parameters after double plateletpheresis. Transfus Apher Sci. 2007 Oct;37(2):161-3. Epub 2007 Oct 23.
Ovali E, Dikmen T, Sonmez M, Yilmaz M, Unal A, Dalbasti T, Kuzeyli K, Erturk M, Omay SB. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study. J Exp Clin Cancer Res. 2007 Jun;26(2):209-14.
Sonmez M, Ovali E, Dikmen T, Yilmaz M, Erturk M, Sonmez B, Omay SB. The role of hepatocyte growth factor in the differentiation of dendritic cells from peripheral blood monocytes. Saudi Med J. 2007 May;28(5):688-95.
Sonmez M, Aydin K, Durmus A, Sucu N, Yilmaz M, Akdogan E, Koksal I, Ovali E, Omay SB. Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever. J Infect. 2007 Aug;55(2):184-7.
Erem C, Deger O, Ovali E, Barlak Y. The effects of royal jelly on autoimmunity in Graves’ disease. Endocrine. 2006 Oct;30(2):175-83.
Caylan R, Bektas D, Dikmen T, Bektas O, Omay SB, Ovali E. Mesenchymal stem cells in iatrogenic facial nerve paralysis: a possible role in the future. Eur Arch Otorhinolaryngol. 2006 Oct;263(10):963-7.
Kavgaci H, Ozdemir F, Ovali E, Yavuz A, Yavuz M, Aydin F. Effect of the farnesyl transferase inhibitor L-744,832 on the colon cancer cell line DLD-1 and its combined use with radiation and 5-FU. Chemotherapy. 2005 Oct;51(6):319-23.
Kaynar K, Ulusoy S, Ovali E, Vanizor B, Dikmen T, Gul S. TGF-beta and TNF-alpha producing effects of losartan and amlodipine on human mononuclear cell culture. Nephrology (Carlton). 2005 Oct;10(5):478-82.
Çetiner M, Fıratlı Tuğlular T, Özen Al Ahdab Y, Al Ahdab H, Köse M, Noyan F, Adıgüzel C, Ovalı E, Bayık M. Amifostine treatment in patients with myelodysplastic syndrome. Turk J Haematol. 2005 Sep 5;22(3):117-23.
Ağaoğlu N, Türkyilmaz S, Ovali E, Uçar F, Ağaoğlu C. Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia. World J Surg. 2005 Sep;29(9):1135-8.
Aliyazicioglu Y, Deger O, Ovali E, Barlak Y, Hosver I, Tekelioglu Y, Karahan SC.Effects of Turkish pollen and propolis extracts on respiratory burst for K-562 cell lines. Int Immunopharmacol. 2005 Oct;5(11):1652-7.
Uçar F, Ovali E, Pakdemir A, Alver A, Gök I, Karti SS, Kalay E. HLA alleles and haplotypes in the east Black Sea Turkish population. Transplant Proc. 2004 Nov;36(9):2610-4.
Erem C, Hacihasanoğlu A, Celik S, Ovali E, Ersöz HO, Ukinç K, Deger O, Telatar M. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract. 2005 Jan-Feb;14(1):22-30.
Sonmez M, Sonmez B, Eren N, Yilmaz M, Karti SS, Ovali E. Effects of interferon-alpha-2a on Th3 cytokine response in multiple myeloma patients. Tumori. 2004 Jul-Aug;90(4):387-9. Alver A, Uçar F, Keha EE, Kalay E, Ovali E. Effects of leptin and insulin on CA III expression in rat adipose tissue. J Enzyme Inhib Med Chem. 2004 Jun;19(3):279-81.
Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, Akdogan E, Eren N, Koksal I, Ovali E, Erickson BR, Vincent MJ, Nichol ST, Comer JA, Rollin PE, Ksiazek TG. Crimean- Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004 Aug;10(8):1379-84.
Ulusoy S, Ovali E, Aydin F, Erem C, Ozdemir F, Kaynar K. Hemostatic and fibrinolytic response to nasal desmopressin in hemodialysis patients. Med Princ Pract. 2004 Nov- Dec;13(6):340-5.
Alver A, Keha EE, Uçar F, Ovali E. The effect of carbonic anhydrase inhibition on leptin secretion by rat adipose tissue. J Enzyme Inhib Med Chem. 2004 Apr;19(2):181-4.
Ozdemir F, Esen N, Ovali E, Tekelioglu Y, Yilmaz M, Aydin F, Kavgaci H, Boruban C. Effects of dexamethasone, all-trans retinoic acid, vitamin D(3) and interferon-alpha on FO myeloma cells. Chemotherapy. 2004 Oct;50(4):190-3. Epub 2004 Sep 3.
Ozdemir F, Ovali E, Aydin F, Kavgaci H, Büyükcelik A, Ucar F, Sönmez M. The in-vitro effects of medroxyprogesterone acetate on acidic pH induced apoptosis of periferal blood mononuclear cells. J Exp Clin Cancer Res. 2004 Mar;23(1):93-5.
Uçar F, Sönmez M, Ovali E, Ozmenoglu M, Karti SS, Yilmaz M, Pakdemir A. MTHFR C677T polymorphism and its relation to ischemic stroke in the Black Sea Turkish population. Am J Hematol. 2004 May;76(1):40-3.
Uçar F, Celik S, Ovali E, Karti SS, Pakdemir A, Yilmaz M, Onder E. Coexistence of prothrombic risk factors and its relation to left ventricular thrombus in acute myocardial infarction. Acta Cardiol. 2004 Feb;59(1):33-9.
Karti SS, Ovali E, Ozgur O, Yilmaz M, Sonmez M, Ratip S, Ozdemir F. Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparin. Hepatogastroenterology. 2003 Nov-Dec;50(54):1864-6.
Ozgür O, Hacihasanoğlu A, Karti SS, Ovali E. Nimesulide-induced fulminant hepatitis. Turk J Gastroenterol. 2003 Sep;14(3):208-10.
Kartı SS, Eren N, Sönmez M, Yılmaz M, Çobanoğlu Ü, Kavgacı H, Bozkaya H, Ovalı E. Leiomyosarcoma of the Uterus Presenting with Thrombotic Thrombocytopenic Purpura. Turk J Haematol. 2003 Sep 5;20(3):163-5.
Karti S, Yilmaz M, Sonmez M, Akdogan R, Ersoz S, Ucar F, Ovali E. Philadelphia negative, Bcr-Abl positive chronic myeloid leukemia associated with pure red cell aplasia. J Exp Clin Cancer Res. 2003 Jun;22(2):341-2.
Kartı SS, Ratıp S, Yılmaz M, Ukınç K, Örem A, Adıgüzel C, Dane F, Kandemir N, Ovalı E, Bayık M.Therapeutic Trial of Cobalamin in Patients with Normal Serum Cobalamin Levels and Predicted Cobalamin Deficiency. Turk J Haematol. 2003 Jun 5;20(2):69-74.
Karti SS, Yilmaz M, Kosucu P, Altun E, Kesen J, Arslan M, Ozgur O, Ovali E. Early medical treatment is life saving in acute Budd-Chiari due to polycythemia vera. Hepatogastroenterology. 2003 Mar-Apr;50(50):512-4.
Ovali E, Ratip S, Ozmenoglu M, Karti SS, Uçar F, Ukinç K, Yilmaz M, Koşucu P. Large volume donor plasmapheresis in inherited thrombophilia implicated in arterial thrombosis. Transfus Apher Sci. 2003 Jun;28(3):201-6.
Ovali E, Ozdemir F, Aydin F, Kavgaci H, Tekelioglu Y, Büyükcelik A, Yilmaz M. The effects of dexamethasone on leukemic cells derived from patients with AML. J Exp Clin Cancer Res. 2003 Mar;22(1):85-9.
Erdöl C, Ovali E, Baykan M. Granulocytic sarcoma presenting as a right atrial mass. Acta Cardiol. 2003 Apr;58(2):155-8.
Bilici M, Tekelioğlu Y, Efendioğlu S, Ovali E, Ulgen M. The influence of olanzapine on immune cells in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2003 May;27(3):483-5.
Kartí SS, Ovalí E, Ratip S, Cetiner M, Direskeneli H, Bayik M, Akoğlu T. Effect of interferonalpha( 2a) on neutrophil adhesion and phagocytosis in chronic myeloid leukemia and Behçet’s disease. Clin Rheumatol. 2002 Jun;21(3):211-4.
Baykan M, Celik S, Uçar F, Kaplan S, Ovali E, Erdöl C. Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction.Anadolu Kardiyol Derg. 2001 Dec;1(4):242-5; AXIV. Turkish.
Kartı SS, Yılmaz M, Altun E, Koşucu P, Arslan M, Ovalı E. Polycythemia Vera Presenting with Fulminant Hepatic Failure Due to Acute Budd-Chiari Syndrome: Case Report. Turk J Haematol. 2002 Mar 5;19(1):43-5.
Celik S, Ovali E, Baykan M, Uçar F, Erdöl C, Durmuş I, Kaplan S. Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction. Acta Cardiol. 2001 Feb;56(1):1-6.
Ilhan O, Uskent N, Arslan O, Arat M, Ozkalemkaş F, Oztürk G, Kalayoglu SB, Ozet A, Tombuloglu M, Arpaci F, Ovali E, Anak S. National survey of hemapheresis practice in Turkey (1998). Transfus Sci. 2000 Jun;22(3):195-201.
Ovali E, Ratip S, Kibaroglu A, Tekelioglu Y, Cetiner M, Karti S, Aydin F, Bayik M, Akoglu T. Role of hepatocyte growth factor in the development of dendritic cells from CD34+ bone marrow cells. Haematologica. 2000 May;85(5):464-9.
Doğan IV, Ovali E, Eti Z, Yayci A, Göğüş FY. The in vitro effects of isoflurane, sevoflurane, and propofol on platelet aggregation. Anesth Analg. 1999 Feb;88(2):432-6. Kapicioğlu S, Baki A, Tekelioğlu Y, Arslan M, Sari M, Ovali E. The inhibiting effect of cola on gastric mucosal cell cycle proliferation in humans. Scand J Gastroenterol. 1998 Jul;33(7):701-3.
Kapîcîoglu S, Sentürk O, Ilgün K, Ovali E. Effect of long-acting somatostatin analogue (octreotide, SMS 201-995) plus calcium channel blocker (verapamil) on gallbladder contraction. Hepatogastroenterology. 1998 Mar-Apr;45(20):420-3.
Aydin F, Ulusoy S, Ovali E. Results of treatment with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) for non-Hodgkin’s aggressive lymphoma analyzed according to the International Prognostic Index. J Chemother. 1997 Dec;9(6):446-51.
Başlar Z, Aktuglu G, Bolaman Z, Büyükkeçeci F, Gezer S, Kansu E, Koçak R, Ovali E, Ruacan S, Sargin D, Tunali A, Tüzüner N, Ulkü B. Incidence of aplastic anemia in Turkey: a hospital-based prospective multicentre study. Leuk Res. 1997 Nov-Dec;21(11-12):1135-9. Aydin F, Ulusoy S, Ovali E, Sonmez M. Effect of high-dose medroxyprogesterone acetate on tumor necrosis factor-alpha release in patients with chemotherapy-induced neutropenia. J Chemother. 1997 Oct;9(5):377-81.
Kapicioğlu S, Gökce E, Kapicioğlu Z, Ovali E. Treatment of migraine attacks with a longacting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia. 1997 Feb;17(1):27- 30.
Orem A, Değer O, Memiş O, Bahadir S, Ovali E, Cimşit G. Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet’s disease. Ann Rheum Dis. 1995 Sep;54(9):726-9.
Ulsoy H, Erciyes N, Ovali E, Kalac N, Ulusoy S, Albayrak D. Anesthesia in Che’diak-Higashi syndrome–case report. Middle East J Anaesthesiol. 1995 Feb;13(1):101-5.
Mustafa NA, Yandi M, Turgutalp H, Ovali E, Aydemir V, Albayrak L. Role of diltiazem in ischemia-reperfusion injury of the intestine. Eur Surg Res. 1994;26(6):335-41.